A proteome-wide association study reveals novel plasma proteins as potential therapeutic targets for metabolic dysfunction-associated steatotic liver disease
Front Endocrinol (Lausanne). 2025 Oct 16;16:1664691. doi: 10.3389/fendo.2025.1664691. eCollection 2025.
Article
Nov 03, 2025